Photonpharma

About:

Photonpharma develops an autologous cell therapy platform for the treatment of solid tumor cancers.

Website: https://photonpharmaceuticals.com/

Description:

Photonpharma develops an autologous cell therapy platform for the treatment of solid tumor cancers. Its technology stimulates a patient’s own immune system to seek out and destroy their cancer cells. The company has a patent-protected process that inactivates the DNA/RNA of a patient’s own tumor cells while leaving the cells alive with all of the unique tumor-specific antigen targets (neoantigens) intact.

Total Funding Amount:

$5.41M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fort Collins, Colorado, United States

Founded Date:

2018-01-01

Contact Email:

admin(AT)photonpharma.net

Founders:

Ray Goodrich

Number of Employees:

1-10

Last Funding Date:

2024-08-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai